Global Transfection Reagents and Equipment Market to Reach US$ 1,766.9 Million by 2032, Impelled by Recent COVID-19 Outbreak

October 28, 2022 | Healthcare

The latest report by IMARC Group, titled "Transfection Reagents and Equipment Market Report by Product (Reagents, Equipment), Technology (Biochemical Based Transfection, Physical Transfection, Viral-Vector Based Transfection), Application (Biomedical Research, Protein Production, Therapeutic Delivery), End User (Pharmaceutical and Biotechnology Companies, Academics and Research Institutes), and Region 2024-2032," finds that the global transfection reagents and equipment market reached a value of US$ 971.1 Million in 2023. Transfection reagents and equipment are used to modulate gene expression in eukaryotic cells in vitro and in vivo. They prevent the production of certain proteins by hindering the translation process and allow researchers to generate stable cell lines and introduce deoxyribonucleic acid (DNA) plasmids for expression and small interfering RNA (siRNA). They also provide cost-effective production of recombinant human therapeutic proteins in sufficient quantities. Owing to these properties, transfection reagents and equipment are widely utilized to produce r-proteins, antibodies, and viral vectors for vaccines.

Global Transfection Reagents and Equipment Market Trends:

The market is primarily driven by the recent outbreak of the coronavirus disease (COVID-19) pandemic across the globe. At present, governing agencies of numerous countries are implementing favorable initiatives to accelerate the vaccination drive. Consequently, due to the emergence of newer variants, transfection reagents and equipment are widely utilized to develop innovative strategies or repurpose existing treatments to fight virus infection. In addition, the increasing detection of new cancer variants and the escalating demand for precision medicine and high-quality oncology treatment are accelerating product adoption in cancer research and drug development. This, coupled with the emergence of gene therapies to treat diseases caused by genetic problems, is positively influencing market growth. Moreover, various advancements in transfection technologies and the increasing investments in biotechnology and pharmaceutical sectors are anticipated to augment market growth in the coming years. Looking forward, IMARC Group expects the market to reach US$ 1,766.9 Million by 2032, exhibiting a CAGR of 6.7% during the forecast period (2024-2032).

Market Summary:

  • Based on the product, the market has been bifurcated into reagents and equipment.
  • On the basis of technology, the market has been segmented into biochemical-based, physical, and viral vector-based transfection.
  • Based on the application, the market has been classified into biomedical research, protein production, and therapeutic delivery.
  • On the basis of the end user, the market has been segregated into pharmaceutical and biotechnology companies, academics and research institutes.
  • Region-wise, the market has been divided into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has been examined in the report, with some of the key players being Bio-Rad Laboratories Inc., Lonza Group AG, MaxCyte Inc., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., PerkinElmer Inc., Polyplus-transfection SA, Promega Corporation, PromoCell GmbH, Qiagen N.V. and Thermo Fisher Scientific Inc.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Transfection Reagents and Equipment Market to Reach US$ 1,766.9 Million by 2032, Impelled by Recent COVID-19 Outbreak
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More